FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
In the present review, the authors report the published evidence on the use of functional imaging with FDG-PET/CT in assessing the final response to treatment in Hodgkin lymphoma. Despite a very high overall Negative Predictive Value of post-chemotherapy PET on treatment outcome ranging from 94% to...
Main Authors: | Andrea Gallamini, Michał Kurlapski, Jan Maciej Zaucha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/3952 |
Similar Items
-
Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
by: Claudia Ortega, et al.
Published: (2023-03-01) -
MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas
by: Francesca Maccioni, et al.
Published: (2021-10-01) -
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
by: Vijay Mistry, et al.
Published: (2023-01-01) -
Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG‐PET/CT
by: Sara Fernández, et al.
Published: (2024-02-01) -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
by: Andrea Gallamini, et al.
Published: (2017-04-01)